Insulin resistance and fertility in polycystic ovary syndrome.
2008

Insulin Resistance and Fertility in Polycystic Ovary Syndrome

publication Evidence: moderate

Author Information

Author(s): Simona Fica, Albu A, Constantin M, Dobri GA

Primary Institution: Carol Davila University of Medicine and Pharmacy, Bucharest

Hypothesis

Insulin resistance plays a central role in the pathogenesis of Polycystic Ovary Syndrome (PCOS) and affects fertility.

Conclusion

Reducing insulin resistance can improve ovulation rates in PCOS patients, but strong evidence supporting the use of insulin-sensitizing drugs for infertility treatment is lacking.

Supporting Evidence

  • PCOS is associated with high rates of infertility due to chronic anovulation.
  • Weight loss has been shown to improve reproductive parameters in overweight and obese PCOS patients.
  • Metformin may induce ovulation in some PCOS patients, but its efficacy for live-birth rates is unclear.

Takeaway

Women with PCOS often have trouble getting pregnant because of insulin problems, but losing weight can help them ovulate better.

Methodology

The study reviewed existing literature on insulin resistance and its impact on fertility in PCOS patients, including treatment strategies.

Potential Biases

Many studies included patients with varying degrees of obesity, which may affect the outcomes and generalizability.

Limitations

The evidence for the efficacy of metformin and other insulin-sensitizing drugs in improving pregnancy outcomes is not conclusive due to the small number of studies.

Participant Demographics

PCOS patients, primarily of reproductive age, with varying degrees of obesity.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication